Dr Reddy’s has announced $50.5 million acquisition of the Stugeron brand from Janssen Pharmaceutica. The deal strengthens its CNS and anti-vertigo portfolio across 18 APAC and EMEA markets, including India and Vietnam, supporting expansion and patient reach goals.